Cargando…

Interferon Lambda 3/4 (IFNλ3/4) rs12979860 Polymorphisms Is Not Associated With Susceptibility to Systemic Lupus Erythematosus, Although It Regulates OASL Expression in Patients With SLE

Systemic lupus erythematosus (SLE) is an autoimmune disease with a complex etiology. Various genetic factors are associated with susceptibility to developing SLE and contribute to its onset and progression. Different single-nucleotide polymorphisms (SNPs) have been associated with SLE in several pop...

Descripción completa

Detalles Bibliográficos
Autores principales: Juárez-Vicuña, Yaneli, Pérez-Ramos, Julia, Adalid-Peralta, Laura, Sánchez, Fausto, Martínez-Martínez, Laura Aline, Ortiz-Segura, María del Carmen, Pichardo-Ontiveros, Edgar, Hernández-Díazcouder, Adrián, Amezcua-Guerra, Luis M., Ramírez-Bello, Julian, Sánchez-Muñoz, Fausto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206639/
https://www.ncbi.nlm.nih.gov/pubmed/34149799
http://dx.doi.org/10.3389/fgene.2021.647487
_version_ 1783708672319291392
author Juárez-Vicuña, Yaneli
Pérez-Ramos, Julia
Adalid-Peralta, Laura
Sánchez, Fausto
Martínez-Martínez, Laura Aline
Ortiz-Segura, María del Carmen
Pichardo-Ontiveros, Edgar
Hernández-Díazcouder, Adrián
Amezcua-Guerra, Luis M.
Ramírez-Bello, Julian
Sánchez-Muñoz, Fausto
author_facet Juárez-Vicuña, Yaneli
Pérez-Ramos, Julia
Adalid-Peralta, Laura
Sánchez, Fausto
Martínez-Martínez, Laura Aline
Ortiz-Segura, María del Carmen
Pichardo-Ontiveros, Edgar
Hernández-Díazcouder, Adrián
Amezcua-Guerra, Luis M.
Ramírez-Bello, Julian
Sánchez-Muñoz, Fausto
author_sort Juárez-Vicuña, Yaneli
collection PubMed
description Systemic lupus erythematosus (SLE) is an autoimmune disease with a complex etiology. Various genetic factors are associated with susceptibility to developing SLE and contribute to its onset and progression. Different single-nucleotide polymorphisms (SNPs) have been associated with SLE in several populations. The rs12979860 SNP in interferon lambda 3/4 (IFNλ3/4) is significantly associated with SLE susceptibility in patients negative for nephritis in Taiwanese people, and interferon-stimulated genes (ISGs) are differentially expressed in normal liver by the rs12979860 genotype. This study aimed to investigate whether rs12979860 is associated with the presence of SLE and lupus nephritis in Mexican individuals as well as with the expression of several ISGs in SLE patients. In total, 439 SLE patients and 358 healthy donors were genotyped for rs12979860 using real-time PCR, and allelic discrimination plots were constructed. Additionally, peripheral blood mononuclear cells (PBMCs) were isolated from the venous blood of SLE patients by centrifugation (n = 78). The mRNA levels of 2′-5′-oligoadenylate synthetase like (OASL), myxovirus resistance 1 (MX1), 2′5′-oligoadenylate synthetase 1 (OAS1), interferon-stimulated gene 15 (ISG15) and lymphocyte antigen 6 complex, locus E (LY6E) were determined using real-time PCR. The distributions of rs12979860 genotypes and allele frequencies were compared between SLE patients and healthy donors; case-control analysis revealed that rs12979860 was not associated with SLE susceptibility (OR 1.18, 95% CI 0.97–1.45, p = 0.08) or with the risk for lupus nephritis (OR 0.913, 95% CI 0.590–1.411, p = 0.682). However, OASL expression levels in PBMCs were significantly different between rs12979860 genotypes in SLE patients: median OASL mRNA levels were significantly higher in patients carrying the CC genotype (197.10, IQR 71.10–411.17) than in those with CT/TT genotypes (173.75, IQR 58.80–278.75, p = 0.016). Our results suggest that the SNP rs12979860 does not play a relevant role in susceptibility to SLE in Mexican individuals. However, IFNλ3/4 genotypes appear to be associated with OASL expression in PBMCs from patients with SLE.
format Online
Article
Text
id pubmed-8206639
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82066392021-06-17 Interferon Lambda 3/4 (IFNλ3/4) rs12979860 Polymorphisms Is Not Associated With Susceptibility to Systemic Lupus Erythematosus, Although It Regulates OASL Expression in Patients With SLE Juárez-Vicuña, Yaneli Pérez-Ramos, Julia Adalid-Peralta, Laura Sánchez, Fausto Martínez-Martínez, Laura Aline Ortiz-Segura, María del Carmen Pichardo-Ontiveros, Edgar Hernández-Díazcouder, Adrián Amezcua-Guerra, Luis M. Ramírez-Bello, Julian Sánchez-Muñoz, Fausto Front Genet Genetics Systemic lupus erythematosus (SLE) is an autoimmune disease with a complex etiology. Various genetic factors are associated with susceptibility to developing SLE and contribute to its onset and progression. Different single-nucleotide polymorphisms (SNPs) have been associated with SLE in several populations. The rs12979860 SNP in interferon lambda 3/4 (IFNλ3/4) is significantly associated with SLE susceptibility in patients negative for nephritis in Taiwanese people, and interferon-stimulated genes (ISGs) are differentially expressed in normal liver by the rs12979860 genotype. This study aimed to investigate whether rs12979860 is associated with the presence of SLE and lupus nephritis in Mexican individuals as well as with the expression of several ISGs in SLE patients. In total, 439 SLE patients and 358 healthy donors were genotyped for rs12979860 using real-time PCR, and allelic discrimination plots were constructed. Additionally, peripheral blood mononuclear cells (PBMCs) were isolated from the venous blood of SLE patients by centrifugation (n = 78). The mRNA levels of 2′-5′-oligoadenylate synthetase like (OASL), myxovirus resistance 1 (MX1), 2′5′-oligoadenylate synthetase 1 (OAS1), interferon-stimulated gene 15 (ISG15) and lymphocyte antigen 6 complex, locus E (LY6E) were determined using real-time PCR. The distributions of rs12979860 genotypes and allele frequencies were compared between SLE patients and healthy donors; case-control analysis revealed that rs12979860 was not associated with SLE susceptibility (OR 1.18, 95% CI 0.97–1.45, p = 0.08) or with the risk for lupus nephritis (OR 0.913, 95% CI 0.590–1.411, p = 0.682). However, OASL expression levels in PBMCs were significantly different between rs12979860 genotypes in SLE patients: median OASL mRNA levels were significantly higher in patients carrying the CC genotype (197.10, IQR 71.10–411.17) than in those with CT/TT genotypes (173.75, IQR 58.80–278.75, p = 0.016). Our results suggest that the SNP rs12979860 does not play a relevant role in susceptibility to SLE in Mexican individuals. However, IFNλ3/4 genotypes appear to be associated with OASL expression in PBMCs from patients with SLE. Frontiers Media S.A. 2021-06-02 /pmc/articles/PMC8206639/ /pubmed/34149799 http://dx.doi.org/10.3389/fgene.2021.647487 Text en Copyright © 2021 Juárez-Vicuña, Pérez-Ramos, Adalid-Peralta, Sánchez, Martínez-Martínez, Ortiz-Segura, Pichardo-Ontiveros, Hernández-Díazcouder, Amezcua-Guerra, Ramírez-Bello and Sánchez-Muñoz. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Juárez-Vicuña, Yaneli
Pérez-Ramos, Julia
Adalid-Peralta, Laura
Sánchez, Fausto
Martínez-Martínez, Laura Aline
Ortiz-Segura, María del Carmen
Pichardo-Ontiveros, Edgar
Hernández-Díazcouder, Adrián
Amezcua-Guerra, Luis M.
Ramírez-Bello, Julian
Sánchez-Muñoz, Fausto
Interferon Lambda 3/4 (IFNλ3/4) rs12979860 Polymorphisms Is Not Associated With Susceptibility to Systemic Lupus Erythematosus, Although It Regulates OASL Expression in Patients With SLE
title Interferon Lambda 3/4 (IFNλ3/4) rs12979860 Polymorphisms Is Not Associated With Susceptibility to Systemic Lupus Erythematosus, Although It Regulates OASL Expression in Patients With SLE
title_full Interferon Lambda 3/4 (IFNλ3/4) rs12979860 Polymorphisms Is Not Associated With Susceptibility to Systemic Lupus Erythematosus, Although It Regulates OASL Expression in Patients With SLE
title_fullStr Interferon Lambda 3/4 (IFNλ3/4) rs12979860 Polymorphisms Is Not Associated With Susceptibility to Systemic Lupus Erythematosus, Although It Regulates OASL Expression in Patients With SLE
title_full_unstemmed Interferon Lambda 3/4 (IFNλ3/4) rs12979860 Polymorphisms Is Not Associated With Susceptibility to Systemic Lupus Erythematosus, Although It Regulates OASL Expression in Patients With SLE
title_short Interferon Lambda 3/4 (IFNλ3/4) rs12979860 Polymorphisms Is Not Associated With Susceptibility to Systemic Lupus Erythematosus, Although It Regulates OASL Expression in Patients With SLE
title_sort interferon lambda 3/4 (ifnλ3/4) rs12979860 polymorphisms is not associated with susceptibility to systemic lupus erythematosus, although it regulates oasl expression in patients with sle
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206639/
https://www.ncbi.nlm.nih.gov/pubmed/34149799
http://dx.doi.org/10.3389/fgene.2021.647487
work_keys_str_mv AT juarezvicunayaneli interferonlambda34ifnl34rs12979860polymorphismsisnotassociatedwithsusceptibilitytosystemiclupuserythematosusalthoughitregulatesoaslexpressioninpatientswithsle
AT perezramosjulia interferonlambda34ifnl34rs12979860polymorphismsisnotassociatedwithsusceptibilitytosystemiclupuserythematosusalthoughitregulatesoaslexpressioninpatientswithsle
AT adalidperaltalaura interferonlambda34ifnl34rs12979860polymorphismsisnotassociatedwithsusceptibilitytosystemiclupuserythematosusalthoughitregulatesoaslexpressioninpatientswithsle
AT sanchezfausto interferonlambda34ifnl34rs12979860polymorphismsisnotassociatedwithsusceptibilitytosystemiclupuserythematosusalthoughitregulatesoaslexpressioninpatientswithsle
AT martinezmartinezlauraaline interferonlambda34ifnl34rs12979860polymorphismsisnotassociatedwithsusceptibilitytosystemiclupuserythematosusalthoughitregulatesoaslexpressioninpatientswithsle
AT ortizseguramariadelcarmen interferonlambda34ifnl34rs12979860polymorphismsisnotassociatedwithsusceptibilitytosystemiclupuserythematosusalthoughitregulatesoaslexpressioninpatientswithsle
AT pichardoontiverosedgar interferonlambda34ifnl34rs12979860polymorphismsisnotassociatedwithsusceptibilitytosystemiclupuserythematosusalthoughitregulatesoaslexpressioninpatientswithsle
AT hernandezdiazcouderadrian interferonlambda34ifnl34rs12979860polymorphismsisnotassociatedwithsusceptibilitytosystemiclupuserythematosusalthoughitregulatesoaslexpressioninpatientswithsle
AT amezcuaguerraluism interferonlambda34ifnl34rs12979860polymorphismsisnotassociatedwithsusceptibilitytosystemiclupuserythematosusalthoughitregulatesoaslexpressioninpatientswithsle
AT ramirezbellojulian interferonlambda34ifnl34rs12979860polymorphismsisnotassociatedwithsusceptibilitytosystemiclupuserythematosusalthoughitregulatesoaslexpressioninpatientswithsle
AT sanchezmunozfausto interferonlambda34ifnl34rs12979860polymorphismsisnotassociatedwithsusceptibilitytosystemiclupuserythematosusalthoughitregulatesoaslexpressioninpatientswithsle